FORTH THERAPEUTICS LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Forth Therapeutics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Forth Therapeutics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
FORTH THERAPEUTICS LIMITED is an active private limited company (company number 15702694) incorporated on 3 May 2024, registered in Canterbury. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 May 2026, showing net assets of £244k and cash of £732k, with 7 employees on average. Net assets fell 89% on the prior period (£2.19m).
By net assets it sits in the top quarter of 59 comparable companies in Kent (median £2,535, upper quartile £84k).
Ownership and control
No active person with significant control is registered.
- Prof Neil Henderson
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 3 May 20242 yrs ago
- Next accounts due
- 29 February 2028in 493 days
- Confirmation statement due
- 17 May 2027in 205 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2026 | £244k | £732k | £439k | £381k | — | — | 7 |
| 31 May 2025 | £2.19m | £2.31m | £336k | £480k | — | — | 5 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £243,748 at 31 May 2026
- Net assets down 25% or more on the prior period-88.8% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 3.07
- Cash at bank of £50,000 or moreCash £731,618
- Incorporated two to five years agoIncorporated 3 May 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 493 days
- Confirmation statement duein 205 days
- Accounts period endNet assets £244k · small accounts
- Accounts period endNet assets £2.19m · small accounts
- Incorporated
Similar companies in Kent
- CORONADO RESEARCH LTDSevenoaks · inc. Jun 2024
- EVREGEN LTDTunbridge Wells · inc. Mar 2024
- JO & JAY LTDCanterbury · inc. Mar 2024
- EYVIVA THERAPEUTICS LTDAshford · inc. Feb 2024
- DISCOVERY START LTDSandwich · inc. Feb 2024
- DISCOVERY SCALE LTDSandwich · inc. Feb 2024
All companies incorporated on 3 May 2024 · in May 2024.
Reminders for FORTH THERAPEUTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.